Brainstorm Cell Therapeutics (BCLI) Agrees with University of California Irvine Medical Center to Participate in Phase 3 Trial of NurOwn in ALS
Tweet Send to a Friend
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) today announced that it has signed a definitive agreement with the University of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
